Navigation Links
MCC Names ACRO Leaders to Board of Directors
Date:7/30/2008

MCC Board Expanded to Include Two ACRO Representatives

WASHINGTON, July 30 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) and the Metrics Champion Consortium (MCC) are pleased to announce the appointment of two representatives from ACRO to the MCC Board of Directors. In an agreement reached earlier this month between the two groups, the MCC, a multidisciplinary organization whose mission is to develop biopharmaceutical performance standards, has expanded its Board of Directors to include two positions representing ACRO, the global association of leading clinical research organizations (CROs).

Paul Colvin, R.Ph., Senior Vice President for Clinical Development, North America, with PPD, and Sean Larkin, Senior Executive Vice President, the Americas, for Late Stage Development with PharmaNet Development Group, have been appointed by the MCC Board of Directors to join the MCC leadership on behalf of ACRO.

Mr. Colvin oversees PPD's North American Phase II-IV operational unit, providing strategic leadership to ensure delivery of international and global clinical research programs and coordination of operational processes. At PharmaNet Development Group, Mr. Larkin is responsible for the North American Regional Monitoring Network, clinical operations in Latin America and Canada, and Phase IV development services. Mr. Colvin and Mr. Larkin will assume their MCC Board seats in August 2008.

"We value the knowledge and perspective ACRO's representatives will bring to MCC's Board of Directors," said Guy Mascaro, MCC President. "ACRO's support for our organization is an important step in building a collaborative environment where sponsors and CROs can work together to improve clinical trial performance."

"The association is pleased to be represented by two outstanding industry leaders such as Paul Colvin and Sean Larkin on the MCC Board of Directors," added ACRO Executive Director Doug Peddicord, Ph.D. "ACRO looks forward to including the CRO industry's expertise on the conduct of clinical trials in MCC's initiatives and to adding the association's voice to the leadership of this valuable cross-industry organization."

ACRO's representatives will serve for one-year terms on MCC's Board of Directors. Mr. Larkin will serve for a special 18-month term to allow for continuity between the two ACRO Board positions with a 6-month overlap between all future representatives.

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association is the voice of the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information on ACRO, please visit http://www.acrohealth.org.

About MCC

The Metrics Champion Consortium (MCC) is an open, multidisciplinary, non-profit organization comprised of biotechnology, pharmaceutical and service provider organizations. The mission of MCC is to develop, through a collaborative process, Performance Metrics within the Biotechnology and Pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers. For more information, please visit http://www.metricschampion.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Cambridge Group Names Philip Marineau a Director
2. The Cambridge Group Names Peter Klein a Director
3. Aethon, Inc. Names New Chief Financial Officer
4. Horizon Therapeutics Names Timothy P. Walbert as President and CEO
5. AARP the Magazine Names the Top 10 Healthiest Places to Live in America
6. Cardica Names Frederick Bauer Vice President of Operations
7. Assurant Health Names Jennifer Kopps-Wagner Senior Vice President and General Counsel
8. MDdatacor Names Gregory Buchholz Chief Operating Officer
9. Zane Benefits Names Halstead New CEO
10. Care Investment Trust Inc. Names Frank E. Plenskofski as Chief Financial Officer and Treasurer
11. University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... The National Association for Children of ... representing the growing community of recovering individuals (now over 23 million), to issue ... policies addressing addiction. , Although many of the presidential candidates of both ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly released ... visualization technology should be used to ensure patient safety when placing an IV ... Standards mandate the use of vein visualization technology in patients with difficult venous ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a Makro ... list for its expertise in eClinical Solutions. DDi has built its solution competency ... needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory and ...
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 ... Companion Diagnostics in Personalized Medicine and Cancer Therapy. ... - High-Growth Diagnostic Testing Markets. - Key Diagnostic ... - Molecular Diagnostics in Genetic Testing. - ... Diagnostics Markets. - Over-the-Counter Diagnostic Products World Markets. ...
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016  Kindred ... focused on saving and improving the lives of pets, ... Technical Section of the New Animal Drug Application (NADA) ... the pivotal field study (KB0120) of Zimeta for the ... by the Company. --> ...
(Date:2/11/2016)... BURLINGAME, Calif. , Feb. 11, 2016  NOIT™ ... announced a special "Gift of Change" campaign to assist ... units. For every such unit sold between February 10, ... a unit to a needy family. The NOIT is ... helping non/limited-verbal autistic individuals develop language skills. ...
Breaking Medicine Technology: